TrialBlood2016

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial.

Elena Santagostino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.